The market opened in green on October 23, 2020, overall volumes in futures & options currently stand at 7,42,90,726 contracts with a turnover of Rs. 52,74,739.96 crore.

Sensex and Nifty tumbled on Thursday; however, a few F&O counters saw long positions being built with sizable open interest.

Thursday's session was extremely volatile with the key benchmark indices closing in the red. Amidst increased volatility, there was a lot of action in the mid-cap counters during Thursday's trading session. 

Tech Mahindra announced on Thursday after the market hours that its wholly-owned subsidiary Tech Mahindra (Americas), Inc. has agreed to acquire 6.03 per cent equity shares in VitalTech Holdings, Inc. It also has an additional option to acquire additional equity of up to 8 per cent until January 2021.

The amount of dividends is quite significant as this has come on the back of the expectation of a weak business environment. The record date published by the company is November 6, 2020.

Leading global information technology, consulting & business process services company, Wipro Limited announced that it has entered into an agreement with SAP SE to deliver SAP Enable Now to help organisations adapt quickly to technological changes and expedite globalisation.

For day trading, important support is seen around 11,770 while resistance is placed around 12,020-12,040 levels; more or less, we expect the index to oscillate in this range.

On Thursday, Indian markets marked an end to its four-day winning streak. In the early deals, SGX Nifty vacillates near the dotted lines, indicating a listless start.

The company has consistently reported strong business inflows over the past two quarters. At the end of the first quarter of the current fiscal, it reported its consolidated order book at Rs 305100 crore.

On Thursday, Aurobindo Pharma informed that it has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Acetaminophen injection, 1,000 mg/ 100 ml single-dose vial (SDV), which is a generic equivalent of Mallinckrodt’s Ofirmev injection.